Xcell Biosciences and Royal Perth Hospital Partner to Develop Next-Generation Automated TIL Manufacturing Workflow Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a leading platform company specializing in cell and gene therapy applications, has announced a…
FDA Approves Blujepa (Gepotidacin) for Uncomplicated UTIs in Patients 12+ GSK plc (LSE/NYSE: GSK) has announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in female adults…
KaliVir to Present at 2025 AACR Annual Meeting KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company specializing in the development of advanced oncolytic immunotherapies, has announced its participation in the upcoming American Association for Cancer Research (AACR) Annual Meeting. The event,…
Bayer Unveils New Heart Failure & Kidney Disease Research at ACC.25 Bayer has announced the presentation of 13 new data analyses from its comprehensive KERENDIA® (finerenone) clinical trial program at the American College of Cardiology (ACC) 74th Annual Scientific Session…
SOLVE FSHD Partners with Transcripta Bio to Accelerate Drug Discovery for FSHD SOLVE FSHD, a venture philanthropy organization committed to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), has announced a strategic collaboration with Transcripta Bio, an innovative AI-driven drug discovery…
WHO Foundation and L’Oréal Partner to Advance Global Skin Health The WHO Foundation and L’Oréal Group, through its Dermatological Beauty division, have announced a landmark four-year partnership aimed at improving global access to skin health treatments. This initiative is particularly…
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company dedicated to advancing the field of minimally invasive surgery, has announced a key leadership transition. Effective April 25, 2025, Randy Clark, the current…
Ant Group has announced significant upgrades to its full-suite AI solutions for the healthcare sector, reinforcing its commitment to supporting hospitals, doctors, and users through cutting-edge artificial intelligence. These advancements aim to enhance operational efficiency, improve patient care, and offer…
Omnicell Appoints Perry A. Genova, PhD, as Chief Technology Officer Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming pharmacy and nursing care delivery, has announced the appointment of Perry A. Genova, PhD, as Senior Vice President…
Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer Byondis BV, an independent biopharmaceutical company dedicated to developing innovative, targeted medicines for cancer patients, has announced the appointment of Christoph Korpus, PhD, MBA, as its new Chief Business Officer…